3
Announcements
Trials
Browse
Landscape
Status
Unknown
2
Recruiting
1
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Hepatocellular
19
Stomach Neoplasms
12
Colorectal Neoplasms
10
Carcinoma, Non-Small-Cell Lung
7
Rectal Neoplasms
6
Esophageal Squamous Cell Carcinoma
5
Pancreatic Neoplasms
4
Esophageal Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Neoplasm Metastasis
3
Nasopharyngeal Carcinoma
3
Lung Neoplasms
3
Triple Negative Breast Neoplasms
2
Endometrial Neoplasms
2
Turcot syndrome
1
Thyroid Neoplasms
1
Squamous Cell Non-small Cell Lung Cancer
1
Spinocerebellar Degenerations
1
Sarcoma
1
Salivary Gland Malignant Neoplasms
1
Resectable NSCLC
1
Recurrence
1
Rare Tumor
1
Ovarian Neoplasms
1
Neuroendocrine Tumors
1
Neuroblastoma
1
Neoplasms
1
NSCLC
1
Microsatellite Stable Metastatic Colorectal Cancer
1
Metastatic Gastroesophageal Junction Adenocarcinoma
1
Interventions
Bevacizumab
9
pembrolizumab
5
lenvatinib
5
durvalumab
5
atezolizumab
5
tremelimumab
3
fludarabine
3
camrelizumab
3
apatinib
3
Ipilimumab
3
Cyclophosphamide
3
regorafenib
2
Riluzole
2
Radiotherapy
2
Nivolumab
2
Magnetic Resonance Imaging
2
Idarubicin
2
Blood Specimen Collection
2
Biopsy
2
yttrium chloride
1
trastuzumab deruxtecan
1
spartalizumab
1
sintilimab
1
pertuzumab
1
ferric carboxymaltose
1
epigallocatechin gallate
1
donafenib
1
cemiplimab
1
brodalumab
1
Yttrium-90
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Liver Neoplasms
×
sintilimab
×
Clear all
NCT05713994
2025-03-25
CCGLC-001
Tongji Hospital
Recruiting
300 enrolled